Queasy rider to Unilever’s health

Equating the company that brings you PG Tips, Persil and Lynx toiletries with the Devil might seem laughable at first. Until you realise that an influential US Christian lobbying group with 1 million members is in deadly earnest about it. The American Family Association is trying to organise a national boycott in a market where Unilever does 20 per cent of its global business. The charge? That Unilever is sponsoring prime-time network programmes that sizzle with sex, violence and profanity – like NYPD Blue.

Serious though this may be, it palls into insignificance compared to another affliction facing Unilever. What might be called npd blues.

Outwardly, Unilever is the model of a highly successful global packaged goods company. Sales and profits mount in a way that few shareholders or City pundits could fault. Over the past three years, Unilever has bought 72 businesses worldwide, the latest of them Reckitt & Colman’s food interests. And it is successfully penetrating some of tomorrow’s most promising markets, China and India.

But Unilever has a problem, which all this aggressive activity helps to mask. It lacks an innovative edge, which in the past has allowed others to beat it where it really matters – with new product development, the company’s long-term life insurance policy.

The company has long since recognised this and put into operation a remedial strategy. The gist of it is accelerated development. Innovation, increasingly sourced from collaborative ventures, is accorded a much greater corporate priority. The product, carefully shielded from bureaucratic interference, is hustled to market and once there rolled out internationally as speedily as possible.

Persil Power might seem to epitomise the folly of this policy. But, as Unilever points out, detergents are only a small part of its overall product portfolio. And, as if to prove the point, top Unilever executives have obligingly refrained from slaughtering a scapegoat.

The worrying thing for Unilever is: could it happen again? Is the “accelerator” experience a syndrome? While a fiasco of Power proportions seems unlikely, results in other areas of product development are not altogether promising. Neither the Liptonice nor Yolka co-ventures have covered themselves in glory. And the jury is out on new products such as Chicken Tonight and Calvin Klein’s cK one fragrance.

Unilever has correctly diagnosed its corporate ailment, but whether the surgery will be successful remains to be seen.

Latest from Marketing Week


Access Marketing Week’s wealth of insight, analysis and opinion that will help you do your job better.

Register and receive the best content from the only UK title 100% dedicated to serving marketers' needs.

We’ll ask you just a few questions about what you do and where you work. The more we know about our visitors, the better and more relevant content we can provide for them. And, yes, knowing our audience better helps us find commercial partners too. Don't worry, we won't share your information with other parties, unless you give us permission to do so.

Register now


Our award winning editorial team (PPA Digital Brand of the Year) ask the big questions about the biggest issues on everything from strategy through to execution to help you navigate the fast moving modern marketing landscape.


From the opportunities and challenges of emerging technology to the need for greater effectiveness, from the challenge of measurement to building a marketing team fit for the future, we are your guide.


Information, inspiration and advice from the marketing world and beyond that will help you develop as a marketer and as a leader.

Having problems?

Contact us on +44 (0)20 7292 3703 or email customerservices@marketingweek.com

If you are looking for our Jobs site, please click here